Brief: Sana Biotechnology Q3 Adjusted EPS USD -0.27 Vs. IBES Estimate USD -0.25
08/11/2024 14:00
Nov 08 (Reuters) - Sana Biotechnology Q3 operating expenses USD 61.761 million. * Q3 net income USD -59.924 million * Q3 EPS USD -0.25 * Q3 adjusted net income USD -64.658 million vs. IBES estimate USD -59.9 million
Recent news on Sana Biotechnology
See all newsSana Biotechnology Inc reports results for the quarter ended June 30 - Earnings Summary
Sana Biotechnology Q2 adjusted loss narrows, beats estimates
Brief: Sana Biotechnology Q2 Adjusted EPS USD -0.13 Vs. IBES Estimate USD -0.15
Sana Biotechnology posts Q1 adjusted loss narrower than expected, extends cash runway
Brief: Sana Biotechnology Q1 Adjusted EPS USD -0.14 Vs. IBES Estimate USD -0.17